| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $420.4M | +6.1% |
| Cost of Revenue | $243.0M | +3.9% |
| Gross Profit | $177.4M | +9.2% |
| R&D Expense | $2.9M | +0.0% |
| SG&A Expense | $75.4M | +18.4% |
| Operating Income | $59.1M | -11.7% |
| Pre-tax Income | $56.8M | -14.0% |
| Income Tax | $11.3M | -14.7% |
| Net Income | $45.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.1M | +90.3% |
| Accounts Receivable | $29.1M | +20.9% |
| Inventory | $110.9M | +4.1% |
| Current Assets | $168.3M | +14.9% |
| Total Assets | $285.6M | +13.3% |
| Current Liabilities | $41.5M | +13.8% |
| Total Liabilities | $60.2M | -16.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.8M | +27.9% |
| Capital Expenditures | $6.7M | +5.6% |
| Investing Cash Flow | -$18.4M | +30.2% |
| Financing Cash Flow | -$19.3M | -165.2% |
| Free Cash Flow | $41.1M | +32.5% |
| -13.8% |
| EPS (Basic) | $1.65 | -13.6% |
| EPS (Diluted) | $1.65 | -13.6% |
| Stockholders' Equity |
| $225.5M |
| +25.3% |